Caption Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-452,200
Closed -$2.89M 1432
2025
Q1
$2.89M Sell
452,200
-479,700
-51% -$4.62M 0.03% 569
2024
Q4
$11.1M Sell
931,900
-197,500
-17% -$3.37M 0.1% 170
2024
Q3
$31.3M Sell
1,129,400
-617,800
-35% -$15.5M 0.5% 37
2024
Q2
$41.7M Buy
1,747,200
+556,800
+47% +$13.1M 0.64% 35
2024
Q1
$21M Buy
1,190,400
+114,500
+11% +$1.69M 0.32% 62
2023
Q4
$17M Buy
1,075,900
+411,600
+62% +$4.25M 0.23% 107
2023
Q3
$5.71M Buy
664,300
+424,300
+177% +$3.01M 0.09% 284
2023
Q2
$1.89M Buy
240,000
+145,000
+153% +$1.01M 0.03% 508
2023
Q1
$708K Hold
95,000
0.01% 708
2022
Q4
$1.12M Buy
+95,000
New +$1.09M 0.02% 709
2022
Q2
Sell
-292,800
Closed -$10.1M 1439
2022
Q1
$10.1M Buy
292,800
+180,000
+160% +$5.84M 0.12% 213
2021
Q4
$5.62M Sell
112,800
-2,200
-2% -$116K 0.06% 416
2021
Q3
$5.29M Hold
115,000
0.06% 437
2021
Q2
$3.44M Buy
+115,000
New +$2.35M 0.04% 490

Other funds holding ASPN

Caption Management's ASPN Position: Q1 2026 in Review

Caption Management sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 36,100 shares — an estimated $102K sold.

Caption Management first reported a position in ASPN in Q2 2021 and held it in 14 quarters. The position peaked at $4.76M in Q2 2023. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Caption Management reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 36,100 Aspen Aerogels shares in Q1 2026, an estimated $102K.
  • Caption Management first reported a position in Aspen Aerogels in Q2 2021 and held it in 14 quarters.
  • Caption Management's Aspen Aerogels position peaked at $4.76M in Q2 2023.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.